Illumina (ILMN) Change in Accured Expenses (2009 - 2026)
Illumina's (ILMN) quarterly Change in Accured Expenses came in at $23.0 million in Q2 2026, up 165.71% on a YoY basis from $8.7 million in Q2 2025, and up 148.94% quarter-over-quarter from -$47.0 million in Q1 2026.
Analysis
Illumina (ILMN) Change in Accured Expenses (2009 - 2026) Analysis & Trends
Illumina (ILMN) has reported Change in Accured Expenses for 18 consecutive years, with $23.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Change in Accured Expenses rose 165.71% year-over-year to $23.0 million; the trailing twelve-month figure through Jun 2026 stood at $67.0 million (up 110.91% YoY), and the FY2024 full-year result was -$440.0 million, down 3033.33% from the prior year.
- Change in Accured Expenses rose to $23.0 million in Q2 2026 per ILMN's latest filing, from -$47.0 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $300.0 million in Q1 2023 and bottomed at -$489.0 million in Q3 2024.
- Historically, Change in Accured Expenses has averaged -$12.1 million across 5 years, with a median of -$34.5 million in 2024.
- The sharpest annual moves came in 2024 and 2025: Change in Accured Expenses plunged 805.56% in 2024, then jumped 302.94% in 2025.
- Over 5 years, Change in Accured Expenses stood at -$45.0 million in 2022, then jumped by 188.89% to $40.0 million in 2023, then tumbled by 185.0% to -$34.0 million in 2024, then surged by 302.94% to $69.0 million in 2025, then plunged by 66.67% to $23.0 million in 2026.
- According to Business Quant data, Change in Accured Expenses over the past three periods registered $23.0 million, -$47.0 million, and $69.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | - |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | -249.00 Mn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 34.00 Mn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | 23.00 Mn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | -4.19 Mn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 3.53 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | - |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | 12.13 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | 3.12 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | -91.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 23.00 Mn |
| Mar 29, 2026 | -47.00 Mn |
| Dec 28, 2025 | 69.00 Mn |
| Sep 28, 2025 | 22.00 Mn |
| Jun 29, 2025 | -35.00 Mn |
| Mar 30, 2025 | -56.00 Mn |
| Dec 29, 2024 | -34.00 Mn |
| Sep 29, 2024 | -489.00 Mn |
| Jun 30, 2024 | 136.00 Mn |
| Mar 31, 2024 | -53.00 Mn |
| Dec 31, 2023 | 40.00 Mn |
| Oct 1, 2023 | -54.00 Mn |
| Jul 2, 2023 | 152.00 Mn |
| Apr 2, 2023 | -123.00 Mn |
| Jan 1, 2023 | 300.00 Mn |
| Apr 3, 2022 | -45.00 Mn |
| Oct 3, 2021 | -81.00 Mn |
| Jul 4, 2021 | 57.00 Mn |
| Apr 4, 2021 | 105.00 Mn |
| Jan 3, 2021 | 61.00 Mn |